2015 Antimicrobial Peptides Gordon Research Conference & Gordon Research Seminar
2015 Antimicrobial Peptides Gordon Research Conference & Gordon Research Seminar
批准号:
8895489
负责人:
Charles L Bevins
金额:
$0.5万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-04-15 至 2015-08-31
关键词:
AddressAntibioticsAttentionAutomobile DrivingAwardBiologicalBody SurfaceCommunitiesDataDiscriminationDiseaseElementsEpithelial CellsEuropeFeedbackFunctional disorderFundingGenderGender IssuesGenesHealthHost DefenseHumanIndividualInternationalItalyLeukocytesLifeLocationMediatingMedicineMicrobeMinorityNatural ImmunityNobel PrizeNorth AmericaOralParticipantPathologistPeptidesPharmacologic SubstancePhilosophyPhysiologyPostdoctoral FellowRenaissanceRequest for ApplicationsResearchResearch PersonnelResearch Project GrantsResortRoleScienceScientistSenior ScientistSeriesSiteStudentsTherapeuticTherapeutic InterventionThinkingTimeTrainingVertebratesWorkantimicrobialantimicrobial peptidedesignfield studygraduate studentimmune functioninnovationinterestmeetingsmembermicrobiomemultidisciplinarynovelpathogenpeerpostersprofessorprogramspublic health relevanceresistant strainsymposium
中文摘要
描述(由申请方提供):第10届戈登抗菌肽研究会议(GRC)将于2015年5月在意大利的巴尔加召开。自1997年启动以来,这一系列非常成功的GRCs一直是推动先天免疫新的跨学科思维的工具。它每隔一年举行一次,被认为是2011年获得诺贝尔医学奖和生理学奖的科学领域中最重要的会议。会议在美国和欧洲之间交替举行,以促进活跃在这一研究领域的大型国际科学家社区的出席。抗菌肽(AMP)是基因编码的抗生素,存在于生命的各个领域,越来越多的证据表明这些肽在各种生物环境中的先天免疫中起着重要作用。会议将重点关注这一不断扩大的多学科研究领域。该计划分为9个口头报告和正在进行的海报会议;所有参与者将被敦促提出一个或其他这些格式。口头报告将包括两个由国际知名演讲者(理查德A教授)的主题演讲。Flavell和Lalita Ramakrishnan)。开幕式将包括青年研究者奖获得者的口头介绍。将从主要海报中选择简短的演讲,注意包括高级,初级和学生水平的科学家。会议讨论的主题包括:生物活性和功能的机制; AMPS对宿主微生物组的影响; AMP在先天免疫中的多种功能; AMP功能障碍,生态失调和疾病;使AMPS发挥作用。与会者有充分的时间进行有组织的讨论和非正式互动。本组织的理念是鼓励多样化的参与,积极吸收年轻科学家、少数民族和身体有缺陷的个人,不存在性别歧视。本次会议的一个创新方面是研究生和博士后在舒适的同行环境中交流新数据和想法的会前论坛。与以往的GRC系列会议一样,2015年的会议有望为介导免疫功能的基本分子的深入科学交流提供一个独特的论坛,并为将其转化为有价值的新型药物的讨论提供一个竞技场。
英文摘要
DESCRIPTION (provided by the applicant): The 10th Gordon Research Conference (GRC) on Antimicrobial Peptides will convene in Barga, Italy in May 2015. This highly successful series of GRCs has been a vehicle for driving new interdisciplinary thinking on innate immunity since its initiation in 1997. It is held every other year and is recognized as the premier and single mos important meeting in a scientific field that was recognized in 2011 by a shared Nobel Prize in Medicine and Physiology. The meeting alternates sites between the US and Europe to facilitate attendance by the large international community of scientists active in this research field. Antimicrobial peptides (AMPs) are gene-encoded antibiotics found across all domains of life, and accumulating evidence points to a fundamental role for these peptides in innate immunity in a variety of biological settings. The conference will focus on this ever-expanding multidisciplinary field of study. The program is divided into 9 sessions of oral presentations and ongoing poster sessions; all participants will be urged to present one or the other of these formats. The oral presentations will include two keynote addresses by internationally renowned speakers (Professors Richard A. Flavell and Lalita Ramakrishnan). The opening session will include an oral presentation by the recipient of the Young Investigator Award. Short talks will be selected from key posters, with attention to include senior, junior and student level scientists. The themes addressed in the sessions include: Mechanisms of Biological Activities and Function; The Impact of AMPS on Host Microbiome; Diverse AMP Functions in Innate Immunity; AMP Dysfunction, Dysbiosis and Disease; Putting AMPS to Work. Ample time for organized discussion and informal interaction amongst participants has been included. The organizational philosophy is to encourage diverse participation and to positively include junior scientists, minorities, and individuals with physical limitations and be without gender discrimination. An innovative aspect of this meeting is the pre-conference forum for graduate students and post-docs to exchange new data and ideas in a comfortable setting of peers. As with past meetings in this GRC series, the 2015 conference promises to provide a unique forum for deep scientific exchange on fundamental molecules that mediate immune functions and provide an arena for the discussion of harnessing them into valuable novel pharmaceuticals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Paneth Cell Secreted Effectors in Mucosal Innate Immunity
-
批准号:9295954
-
项目类别:
-
资助金额:$46.16万
-
财政年份:2016
-
负责人:Charles L Bevins
-
依托单位:
New Mouse Models of Paneth Cell Defensin Function
-
批准号:8422985
-
项目类别:
-
资助金额:$19.21万
-
财政年份:2012
-
负责人:Charles L Bevins
-
依托单位:
New Mouse Models of Paneth Cell Defensin Function
-
批准号:8286104
-
项目类别:
-
资助金额:$23.07万
-
财政年份:2012
-
负责人:Charles L Bevins
-
依托单位:
Defensin gene copy number and mucosal innate immunity
-
批准号:7819960
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2010
-
负责人:Charles L Bevins
-
依托单位:
In vivo Models of Defensin Activity
-
批准号:6883922
-
项目类别:
-
资助金额:$30.99万
-
财政年份:2002
-
负责人:Charles L Bevins
-
依托单位:
In vivo Models of Defensin Activity
-
批准号:6620934
-
项目类别:
-
资助金额:$3.05万
-
财政年份:2002
-
负责人:Charles L Bevins
-
依托单位:
In vivo Models of Defensin Activity
-
批准号:6854401
-
项目类别:
-
资助金额:$27.58万
-
财政年份:2002
-
负责人:Charles L Bevins
-
依托单位:
In vivo Models of Defensin Activity
-
批准号:7026937
-
项目类别:
-
资助金额:$30.26万
-
财政年份:2002
-
负责人:Charles L Bevins
-
依托单位:
In vivo Models of Defensin Activity
-
批准号:6423661
-
项目类别:
-
资助金额:$32.1万
-
财政年份:2002
-
负责人:Charles L Bevins
-
依托单位:
In vivo Models of Defensin Activity
-
批准号:6693823
-
项目类别:
-
资助金额:$31.14万
-
财政年份:2002
-
负责人:Charles L Bevins
-
依托单位:
2001 Antimicrobial Peptides Gordon Conference
-
批准号:6368399
-
项目类别:
-
资助金额:$0.38万
-
财政年份:2001
-
负责人:Charles L Bevins
-
依托单位:
NOVEL DEFENSINS IN HUMAN EPITHELIAL TISSUE
-
批准号:2067628
-
项目类别:
-
资助金额:$23.53万
-
财政年份:1993
-
负责人:Charles L Bevins
-
依托单位:
NOVEL DEFENSINS IN HUMAN EPITHELIAL TISSUE
-
批准号:6510700
-
项目类别:
-
资助金额:$25.95万
-
财政年份:1993
-
负责人:Charles L Bevins
-
依托单位:
NOVEL DEFENSINS IN HUMAN EPITHELIAL TISSUE
-
批准号:2688491
-
项目类别:
-
资助金额:$23.05万
-
财政年份:1993
-
负责人:Charles L Bevins
-
依托单位:
Novel Defensins of Human Epithelia
-
批准号:7477101
-
项目类别:
-
资助金额:$31.47万
-
财政年份:1993
-
负责人:Charles L Bevins
-
依托单位:
Novel Defensins of Human Epithelia
-
批准号:7088896
-
项目类别:
-
资助金额:$32.93万
-
财政年份:1993
-
负责人:Charles L Bevins
-
依托单位:
NOVEL DEFENSINS IN HUMAN EPITHELIAL TISSUE
-
批准号:2067627
-
项目类别:
-
资助金额:$20.25万
-
财政年份:1993
-
负责人:Charles L Bevins
-
依托单位:
NOVEL DEFENSINS IN HUMAN EPITHELIAL TISSUE
-
批准号:2886752
-
项目类别:
-
资助金额:$23.75万
-
财政年份:1993
-
负责人:Charles L Bevins
-
依托单位:
NOVEL DEFENSINS IN HUMAN EPITHELIAL TISSUE
-
批准号:3147858
-
项目类别:
-
资助金额:$19.11万
-
财政年份:1993
-
负责人:Charles L Bevins
-
依托单位:
Novel Defensins of Human Epithelia
-
批准号:7216832
-
项目类别:
-
资助金额:$32.08万
-
财政年份:1993
-
负责人:Charles L Bevins
-
依托单位:
海外基金